Portage Biotech Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PRTG Company Description
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
PRTG Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PRTG Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PRTG by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRTG's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of PRTG in WallStreetBets Daily Discussion
PRTG News
Recent insights relating to PRTG
CNBC Recommendations
Recent picks made for PRTG stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PRTG
Corporate Flights
Flights by private jets registered to PRTG
Our Analysis